Novartis Plans For Alcon Spin-off On April 9, 2019
Biogen, Eisai To Discontinue Phase 3 ENGAGE And EMERGE Trials Of Aducanumab
Bayer Now Focuses On Collaborating In Specific Digital Health Focus Areas
Merck KGaA Plans To Invest EUR 1 Bln At Darmstadt Site Until 2025
Merck, NGM Bio Extend Broad, Multi-Year Strategic Collaboration To 2022
Merck KGaA Opens New M Lab Collaboration Center In Molsheim, France
Baxter, BioMérieux To Improve Identification, Treatment Of Acute Kidney Injury